Related Experiment Video
Updated: Aug 19, 2026

Laparoscopic Repair of Para-Esophageal Hernia Using Absorbable Biosynthetic Mesh
Published on: September 11, 2021
Inguinal hernia--laparoscopic or open repair? The case for laparoscopic repair
1Minimal Access Therapy Training Unit, Royal Surrey County Hospital, Guildford GU2 5XX, UK.
Annals of the Royal College of Surgeons of England
|February 22, 2005
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Evaluating large language models in patient education: a comparative analysis addressing frequently asked questions in peri-acetabular osteotomy.
Annals of the Royal College of Surgeons of England·2026
Implementing day-case parathyroidectomy in a large multi-site UK trust: a prospective case series.
Annals of the Royal College of Surgeons of England·2026
Comparative outcomes of genicular nerve block and radiofrequency ablation in knee osteoarthritis.
Annals of the Royal College of Surgeons of England·2026
TOEPVA: a systematic review and meta-analysis of safety, efficacy and feasibility.
Annals of the Royal College of Surgeons of England·2026
Potential underutilisation of weight loss medications in obese patients with knee osteoarthritis.
Annals of the Royal College of Surgeons of England·2026
A service evaluation of surgical interventions for external rectal prolapse in Wales.
Annals of the Royal College of Surgeons of England·2026
Cryptococcosis in immunocompromised patients without HIV infection: experience of a hospital in Chile.
Revista iberoamericana de micologia·2026
Diagnostic Yield and Cost of Morphology-Guided Immunohistochemistry in Liver Tumors.
Asian Pacific journal of cancer prevention : APJCP·2026
Single-cell transcriptomic profiling of cerebrospinal fluid reveals immune-cell heterogeneity and multicompartment MIF/CD74-related communication in tuberculous and purulent meningitis.
Frontiers in cellular and infection microbiology·2026
Persistent CD8+ T-cell activation (HLA-DR/CD38) as an immunological marker in antiretroviral-treated human immunodeficiency virus-1 patients: A cross-sectional study.
The Journal of international medical research·2026